No Detail Found!

Diabetic Macular Edema

Author(s)
Fatih C. Gundogan GATA Medical School, Ophthalmology, Ankara, Turkey
Umit Yolcu Sarikamis Military Hospital, Ophthalmology, Kars, Turkey.
Fahrettin Akay İzmir Military Hospital, Ophthalmology, Izmir, Turkey.
Abdullah Ilhan Erzurum Military Hospital, Ophthalmology, Erzurum, Turkey.
Gokhan Ozge GATA Medical School, Ophthalmology, Ankara, Turkey.
Salih Uzun Etimesgut Military Hospital, Ophthalmology, Ankara, Turkey.
Abstract
Diabetic macular edema (DME), one the most prevalent causes of visual loss in industrialized countries, may be diagnosed at any stage of diabetic retinopathy. The diagnosis, treatment, and follow up of DME have become straightforward with recent developments in fundus imaging, such as optical coherence tomography. Laser photocoagulation, intravitreal injections, and pars plana vitrectomy surgery are the current treatment modalities; however, the positive effects of currently available intravitreally injected agents are temporary. At this point, further treatment choices are needed for a permanent effect. Sources of data selection: The articles published between 1985-2015 years on major databases were searched and most appropriate 40 papers were used to write this review article.
Publication Details
Page(s) 505-510
DOI 10.12669/pjms.322.8496
Published Journal: Pakistan Journal of Medical Sciences, Volume: 32, Issue: 2, Year: 2016

Request the full text from PASTIC

Keywords
Bevacizumab, triamcinolone acetonide, Pars plana vitrectomy, Optical coherence tomography, Diabetic macular edema, Ranibizumab, Fluorescein angiography
More from Pakistan Journal of Medical Sciences
0

Citations

0

Downloads

61

Views

Copyright ©  PASTIC National Center, Islamabad www.pastic.gov.pk